Actualizaciones regulatorias

Novedades regulatorias de FDA, EMA, TGA y organismos globales

#Latanoprost ×

Actualizaciones regulatorias

5 sept 2026•1 min de lectura

FDA Approves Apotex Latanoprost Ophthalmic Solution (ANDA077697)

The FDA approved Apotex's ANDA077697 for a generic latanoprost ophthalmic solution, with labeling supplements approved in 2012 and 2015.